HOOD Stock Falls To Over 6-Month Lows – Piper Sandler Flags Three Near-Term Risks But Retail Sees Buying Opportunity Piper Sandler cited softer cryptocurrency trading volumes, the end of the football season weighing on prediction market revenue, and rising doubts about the momentum of retail trading as reasons for the downtrend.
1 No-Brainer International Vanguard ETF to Buy Right Now for Less Than $1,000 International stocks have lagged the S&P 500 for years, but that's starting to change. Here's one Vanguard ETF that you should target to profit from this shift.
Westfuller Advisors Doubles Down on Ultra-Short Treasuries With Second Cash ETF Focused on ultra-short U.S. Treasury exposure, VBIL targets liquidity and capital preservation for institutional and individual investors.
Affiance Financial Bets $43 Million on Chuck Akre's "Compounding Machines" ETF AKRE is a concentrated ETF emphasizing high-quality U.S. equities and disciplined stock selection.
Obermeyer Loads Up On 187K TBIL Shares As the ETF May Soon Be Tokenized Obermeyer recently purchased $9 million worth of shares in an ETF that may soon be available to own on the blockchain.
SNDK Stock Soars Pre-Market Following Sandisk’s Blowout Q2 Report, Analyst Says Demand Is 'Exceptionally' Strong Raymond James analyst Melissa Fairbanks upgraded Sandisk to ‘Outperform’ from ‘Market Perform’ rating, with a price target of $725.
Pullen Sells $3 Million of TETRA Technologies Stock This energy services firm provides specialized fluids and water management solutions to oil and gas operators worldwide.
Tesla’s Car Lineup Will Soon Be Less S3XY As Musk Pitches $20B Pivot Into Autonomy, Robotics The company now eyes 2026 capital expenditure of about $20 billion, up from the $8.5 billion reported in 2025.
3 Vanguard ETFs to Buy With $1,000 and Hold Forever Each ETF has a different focus, covering a lot of investing ground.
Eli Lilly Strikes $1.1 Billion Deal With Seamless Therapeutics To Develop Gene Therapies For Hearing Loss Under the terms of the deal between Seamless Therapeutics and Eli Lilly, Seamless will design and program site-specific enzymes to correct mutations in certain genes related to hearing loss.
PYPL Stock Hit With A Downgrade As 'Marginal Consumer' Moves Away From Its Platform According to TheFly, analysts at Rothschild & Co Redburn downgraded PayPal to ‘Sell’ from ‘Neutral’ and lowered the price target to $50 from $70.
